Sweden Sterile Injectable Contract Manufacturing Market Size & Outlook

The sterile injectable contract manufacturing market in Sweden is expected to reach a projected revenue of US$ 318.5 million by 2030. A compound annual growth rate of 8% is expected of Sweden sterile injectable contract manufacturing market from 2025 to 2030.
Revenue, 2024 (US$M)
$201.2
Forecast, 2030 (US$M)
$318.5
CAGR, 2025 - 2030
8%
Report Coverage
Sweden

Sweden sterile injectable contract manufacturing market, 2018-2030 (US$M)

Sweden

Related Markets

Sweden sterile injectable contract manufacturing market highlights

  • The Sweden sterile injectable contract manufacturing market generated a revenue of USD 201.2 million in 2024 and is expected to reach USD 318.5 million by 2030.
  • The Sweden market is expected to grow at a CAGR of 8% from 2025 to 2030.
  • In terms of segment, large molecule was the largest revenue generating molecule type in 2024.
  • Large Molecule is the most lucrative molecule type segment registering the fastest growth during the forecast period.

Sterile injectable contract manufacturing market data book summary

Market revenue in 2024USD 201.2 million
Market revenue in 2030USD 318.5 million
Growth rate8% (CAGR from 2024 to 2030)
Largest segmentLarge molecule
Fastest growing segmentLarge Molecule
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSmall Molecule, Large Molecule
Key market players worldwideBaxter International Inc, Catalent Inc, Recipharm, Fresenius SE & Co KGaA, Cipla Ltd DR, Vetter Pharma-Fertigung, Aenova Group, Unither Pharmaceuticals, Famar, Sorrento Therapeutics Inc

Other key industry trends

  • In terms of revenue, Sweden accounted for 1.3% of the global sterile injectable contract manufacturing market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany sterile injectable contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 1,354.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sterile Injectable Contract Manufacturing Market Companies

Name Profile # Employees HQ Website

Sweden sterile injectable contract manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sterile injectable contract manufacturing market will help companies and investors design strategic landscapes.


Large molecule was the largest segment with a revenue share of 66.9% in 2024. Horizon Databook has segmented the Sweden sterile injectable contract manufacturing market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Sweden sterile injectable contract manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Sweden sterile injectable contract manufacturing market databook

  • Our clientele includes a mix of sterile injectable contract manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Sweden sterile injectable contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Sweden sterile injectable contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sweden sterile injectable contract manufacturing market size, by molecule type, 2018-2030 (US$M)

Sweden Sterile Injectable Contract Manufacturing Market Outlook Share, 2024 & 2030 (US$M)

Sweden sterile injectable contract manufacturing market size, by molecule type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more